Literature DB >> 22684895

MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII.

Xiaofeng Jiang1, Guangyang Xiang, Yezeng Wang, Lei Zhang, Xuewei Yang, Liangqi Cao, Heping Peng, Ping Xue, De Chen.   

Abstract

MicroRNAs (miRNAs) are regulatory small non-coding RNAs that can regulate gene expression by binding to gene elements, such as the gene promotor 5'UTR, mainly in the 3'UTR of mRNA. One miRNA targets many mRNAs, which can be regulated by many miRNAs, leading to a complex metabolic network. In our study, we found that the expression level of miR-590-5p is higher in the human hepatocellular carcinoma cell line HepG2 than in the normal hepatocellular cell line L02. Downregulation of miR-590-5p inhibited proliferation and invasion of hepatocellular carcinoma cells (HCCs). We also showed that expression of TGF-beta RII, which has been regarded as a regulator of tumor proliferation, invasion, and migration in hepatocellular carcinoma, is regulated by miRNA-590-5p. In addition, miR-590-5p downregulated the expression of TGF-beta RII by targeting the 3'UTR of mRNA. We also found that downregulation of miR-590-5p was associated with an elevation of TGF-beta RII and inhibition of proliferation and invasion in HepG2 cells. Furthermore, overexpression of miR-590-5p was associated with upregulation of TGF-beta RII and could promote proliferation and invasion in L02 cells. In conclusion, we determined that TGF-beta RII is a novel target of miRNA-590-5p. Thus, the role of TGF-beta RII in regulating proliferation and invasion of human HCCs is controlled by miR-590-5p. In other words, miR-590-5p promotes proliferation and invasion in human HCCs by directly targeting TGF-beta RII.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684895      PMCID: PMC3887758          DOI: 10.1007/s10059-012-2267-4

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  23 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.

Authors:  T Fukushima; M Mashiko; K Takita; T Otake; Y Endo; K Sekikawa; S Takenoshita
Journal:  J Exp Clin Cancer Res       Date:  2003-06

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

Authors:  Hector Peinado; Miguel Quintanilla; Amparo Cano
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

Review 5.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.

Authors:  P Bedossa; E Peltier; B Terris; D Franco; T Poynard
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

8.  MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.

Authors:  Tao Liu; Hua Tang; Yuanyuan Lang; Min Liu; Xin Li
Journal:  Cancer Lett       Date:  2008-09-13       Impact factor: 8.679

9.  MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.

Authors:  Srinivas Veerla; David Lindgren; Anders Kvist; Attila Frigyesi; Johan Staaf; Helena Persson; Fredrik Liedberg; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Carlos Rovira; Mattias Höglund
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  34 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.

Authors:  Iván Lyra-González; Laura E Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  World J Hepatol       Date:  2015-06-18

3.  MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells.

Authors:  Jae-Sung Kim; Sun-Kyoung Yu; Myoung-Hwa Lee; Min-Gyeong Park; Euteum Park; Su-Gwan Kim; Sook-Young Lee; Chun Sung Kim; Heung-Joong Kim; Hong Sung Chun; Sang-Woo Chun; Do Kyung Kim
Journal:  Mol Cells       Date:  2012-12-03       Impact factor: 5.034

Review 4.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

5.  Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor.

Authors:  Yaqin Zhou; Zhangchuan Xia; Zhikui Cheng; Gang Xu; Xiaodan Yang; Shi Liu; Ying Zhu
Journal:  J Biol Chem       Date:  2018-10-05       Impact factor: 5.157

6.  MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.

Authors:  Wei-Wei Bao; You-Ling Shi; Yan Ma; Xing-Hui Qu; Guang-Ming Pang; Lei Yang
Journal:  Histol Histopathol       Date:  2021-01-15       Impact factor: 2.303

Review 7.  MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

Authors:  Jie Sun; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  ScientificWorldJournal       Date:  2013-02-04

8.  MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.

Authors:  Savita Singh; Girish C Shukla; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

9.  miR-590-5p targets RMND5A and promotes migration in pancreatic adenocarcinoma cell lines.

Authors:  Sixing Chen; Yu Chen; Yao Wen; Wanwan Cai; Ping Zhu; Wuzhou Yuan; Yongqing Li; Xiongwei Fan; Yongqi Wan; Fang Li; Jian Zhuang; Zhigang Jiang; Xiushan Wu; Yuequn Wang
Journal:  Oncol Lett       Date:  2021-05-17       Impact factor: 2.967

10.  miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway.

Authors:  Jinchun Shang; Shukai Sun; Lin Zhang; Fengyun Hao; Dianlong Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.